For an adult with chronic rhinosinusitis, the surgeon should not endorse or require a predefined regimen or duration of medical therapy as a prerequisite to sinus surgery. HealthDay News — In a new ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified three subtypes of chronic rhinosinusitis and trajectories of asthma and allergy with ...

Sinuses are interconnected, hollow spaces located in the skull that connect to the nasal passages. They help filter the air we breathe and act as another level of immune defense. Sinuses are lined ...

When treating chronic rhinosinusitis, antibiotics should be used selectively, said Alexander Duffy, MD, division chief of Rhinology & Anterior Skull Base Surgery at Temple University Hospital in ...

The FDA expanded the approval of fluticasone propionate (Xhance) nasal spray for chronic rhinosinusitis to also include treatment of adults without nasal polyps, manufacturer Optinose announced on ...

Dupilumab (Dupixent) has gained FDA approval for the treatment of chronic rhinosinusitis with nasal polyps, marking the first biologic approved for adults with inadequately controlled disease. Chronic ...

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis. A new CT-scan based risk score facilitates the ...

The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal polyps to include adolescents as well, Regeneron Pharmaceuticals and Sanofi ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Verekitug is the only known thymic stromal lymphopoietin ...

Fall can be a tough time for people prone to sinusitis, which is more commonly known as a sinus infection. Not only is allergy season in full swing, but the common cold also starts circulating, and ...

Findings showed treatment with Xhance was associated with a statistically significant improvement on both study endpoints compared with placebo. The Food and Drug Administration (FDA) has approved ...